SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
基本信息
- 批准号:6537755
- 负责人:
- 金额:$ 38.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-04-01 至 2005-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Pneumocystis carinii (Pc) is a fungus of low virulence that is major cause of
pneumonia (P) in HIV patients. Surfactant protein (SP-A), a member of the
collectins, plays an important role in the host's innate immunity against
pulmonary pathogens. Studies of the interaction of SP-A with Pc have mainly
been conducted in vitro and have produced conflicting results. Gene targeted
mice deficient in SP-A appear more susceptible to PcP than wild type mice
administered the same immunosuppression. The application proposes the
following hypotheses: SP-A facilitates the clearance of Pc in the
immunocompetent host; this activity can be localized to specific domains of
SP-A and is mediated at least in part by alveolar macrophages; SP-A delays the
development and reduces the severity of PcP in the immunocompromised host;
SP-A down regulates the host immune/inflammatory response to Pc. The specific
aims are: 1) To analyze the effects of SP-A on Pc infection in the
immunocompetent host. These studies will: 1.1) investigate the effects of
SP-A on the clearance of Pc from the lungs; 1.2) determine if the
administration of SP-A can reverse the changes in SP-A deficient mice and to
localize the specific domains involved; 1.3) study the effects of SP-A on the
interaction of Pc with alveolar macrophages; and 1.4) analyze the effects of
SP-A on the host immune/inflammatory response to Pc infection. 2) To analyze
the effects of SP-A on PcP in the immunocompromised host. These studies will:
2.1) analyze the effects of SP-A on the development of PcP induced by
different forms of immunosuppression; 2.2) examine the influence of SP-A on
the changes in alveolar cells, sufactant constituents, and lung function that
occur with PcP; and 2.3) analyze the influence of SP-A on the host
immune/inflammatory response that occurs during the recovery from PcP.
卡氏肺囊虫(Pc)是一种低毒力的真菌,是引起卡氏肺囊虫病的主要原因
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PETER D WALZER其他文献
PETER D WALZER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PETER D WALZER', 18)}}的其他基金
Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
- 批准号:
7188525 - 财政年份:2005
- 资助金额:
$ 38.25万 - 项目类别:
Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
- 批准号:
7585265 - 财政年份:2005
- 资助金额:
$ 38.25万 - 项目类别:
Global Serological Study of Pneumocystis Infection
肺孢子虫感染的全球血清学研究
- 批准号:
7114021 - 财政年份:2005
- 资助金额:
$ 38.25万 - 项目类别:
Global Serological Study of Pneumocystis Infection
肺孢子虫感染的全球血清学研究
- 批准号:
6934161 - 财政年份:2005
- 资助金额:
$ 38.25万 - 项目类别:
Serum Antibodies to Recombinant Pneumocystis Antigens
重组肺孢子虫抗原的血清抗体
- 批准号:
7388815 - 财政年份:2005
- 资助金额:
$ 38.25万 - 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
- 批准号:
6077013 - 财政年份:2000
- 资助金额:
$ 38.25万 - 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
- 批准号:
6638606 - 财政年份:2000
- 资助金额:
$ 38.25万 - 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
- 批准号:
6390669 - 财政年份:2000
- 资助金额:
$ 38.25万 - 项目类别:
SP-A MOUSE MODELS OF PNEUMOCYSTIS INFECTION
肺孢子虫感染的 SP-A 小鼠模型
- 批准号:
6735630 - 财政年份:2000
- 资助金额:
$ 38.25万 - 项目类别:
PNEUMOCYSITIS CARINII INFECTION THERAPIES--PRECLIN EVAL
卡氏肺囊虫感染治疗 - PRECLIN 评估
- 批准号:
6334487 - 财政年份:1997
- 资助金额:
$ 38.25万 - 项目类别:
相似海外基金
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10605177 - 财政年份:2020
- 资助金额:
$ 38.25万 - 项目类别:
Prevention and Treatment of Pneumocystis Pneumonia
肺孢子虫肺炎的防治
- 批准号:
10382422 - 财政年份:2020
- 资助金额:
$ 38.25万 - 项目类别:
Development of a vaccine to prevent Pneumocystis pneumonia
开发预防肺孢子虫肺炎的疫苗
- 批准号:
9906567 - 财政年份:2020
- 资助金额:
$ 38.25万 - 项目类别:
Pathogenesis of spontaneous pneumocystis pneumonia in Caspase8 and Ripk3 double deficient mice
Caspase8和Ripk3双缺陷小鼠自发性肺孢子虫肺炎的发病机制
- 批准号:
19K17650 - 财政年份:2019
- 资助金额:
$ 38.25万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
- 批准号:
10001636 - 财政年份:2018
- 资助金额:
$ 38.25万 - 项目类别:
Therapeutic antibodies to treat Pneumocystis pneumonia in a nonhuman primate model of HIV infection
在 HIV 感染的非人灵长类动物模型中治疗肺孢子虫肺炎的治疗性抗体
- 批准号:
9624861 - 财政年份:2018
- 资助金额:
$ 38.25万 - 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子菌肺炎的补充疗法
- 批准号:
9063354 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:
Vitamin D as Supplemental Therapy for Pneumocystis Pneumonia
维生素 D 作为肺孢子虫肺炎的补充疗法
- 批准号:
9238656 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
- 批准号:
10521311 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
改进肺孢子虫肺炎的治疗和诊断
- 批准号:
9210593 - 财政年份:2016
- 资助金额:
$ 38.25万 - 项目类别:














{{item.name}}会员




